Health‐related quality of life in adults with osteogenesis imperfecta-Reference-Cited by-同舟云学术

Health‐related quality of life in adults with osteogenesis imperfecta

Published:2021-02-22 Issue:6 Volume:99 Page:772-779
ISSN:0009-9163
Container-title:Clinical Genetics
language:en
Short-container-title:Clinical Genetics

Author:

Murali Chaya N.¹²^ORCID,Slater Brady¹,Musaad Salma³⁴,Cuthbertson David⁵,Nguyen Dianne¹,Turner Alicia¹,Azamian Mahshid¹,Tosi Laura⁶,Rauch Frank⁷,Sutton V. Reid¹²,Lee Brendan¹²,Nagamani Sandesh C. S.¹²^ORCID,

Affiliation:

1. Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas USA

2. Texas Children's Hospital Houston Texas USA

3. Department of Pediatrics‐Nutrition Baylor College of Medicine Houston Texas USA

4. Children's Nutrition Research Center United States Department of Agriculture/Agricultural Research Service Houston Texas USA

5. College of Medicine University of South Florida Tampa Florida USA

6. Bone Health Program Children's National Health System Washington D.C. Washington USA

7. Shriner's Hospital of Children McGill University Montreal Quebec Canada

Funder

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Center for Advancing Translational Sciences

National Institutes of Health

Osteogenesis Imperfecta Foundation

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cge.13939

Reference38 articles.

1. US Food and Drug Administration.Guidance for industry: patient‐reported outcome measures: use in medical product development to support labeling claims 2009.https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/UCM193282.pdf.

2. Patient reported outcome measures in rare diseases: a narrative review

3. Quality of life in rare genetic conditions: A systematic review of the literature

4. US Food and Drug Administration.Rare diseases: common issues in drug development guidance for industry DRAFT guidance 2019.https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/default.htm.

5. To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life of pediatric and adult individuals with osteogenesis imperfecta: a meta-analysis;Orphanet Journal of Rare Diseases;2023-05-24

2. Cross-cultural adaptation, reliability and validation of the Gillette Functional Assessment Questionnaire (FAQ) into Brazilian Portuguese in patients with cerebral palsy;BMC Pediatrics;2023-04-11

3. Systematic review of health related-quality of life in adults with osteogenesis imperfecta;Orphanet Journal of Rare Diseases;2023-02-22

4. A multicenter study to evaluate pain characteristics in osteogenesis imperfecta;American Journal of Medical Genetics Part A;2022-10-22